Latest presentation by Compumedics is suggesting possible US listing and the valuation of compumedics in several years may be worth between US$300m and US$500m . This implies they are going to get revenue up from its current $36-40m per year up to $100m. Considering Compumedics have almost no debt and a market cap of only $23m might suggest that its stock price might move out from 10year lows.
Even if the business was SOLD with current revenues of around $36-40m it could still get 1.5 times revenue. This would be worth around 34-38c a share. Being listed in the US would imply a higher multiple on npat as suggested in the presentation and thats where they come up with the 300-500m valuation.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)